Alto Neuroscience, Inc.
  • Los Altos, CA, USA
  • Full Time

Company Information

Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Currently, there is no objective way to diagnose psychiatric illness, nor to identify which treatment is best for an individual patient. Treatment selection is presently done by trial-and-error as there are no tests that can inform these decisions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients' brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. We aim to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most. Come join us on our mission to re-imagine and re-engineer the treatment of mental illnesses!

Roles and Responsibilities

  • Use statistical tools to draw valid inferences about CNS disease progression from cleaned biometric feature data
  • Elucidate and communicate the biological underpinnings of derived findings
  • Contribute to Clinical Study Reports (CSRs), especially results sections

Skills and Qualifications

  • MS or Ph.D. in biostatistics, statistics, psychology, neuroscience, or related field
  • 3-5 years of experience analyzing clinical and/or cognitive assessment data. Experience with pharmaceutical RCT data is a plus
  • Experience with statistical programming languages such as SAS, R, or SPSS. Experience with Python is also a plus
  • Pharmaceutical / biotech clinical development process is preferred
  • Excellent communication skills
  • Eager to thrive in a startup environment
Alto Neuroscience, Inc.
  • Apply Now

    with our quick 3 minute Application!

  • * Fields Are Required

    What is your full name?

    How can we contact you?

  • Sign Up For Job Alerts!

  • Share This Page
  • Facebook Twitter LinkedIn Email
.
Logo About Platform Programs Press and News